The nondietary determinants of vitamin D status in pediatric inflammatory bowel disease

Nutrition

Volumn 31, Issue 7-8, 2015, Pages 994-999

  Veit, Lauren E ^a   Maranda, Louise ^a   Nwosu, Benjamin Udoka ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Adiposity; Alanine transaminase; Crohn's disease; Hepatic inflammation; Hypoalbuminemia; Inflammatory bowel disease; Intestinal inflammation; Protein losing enteropathy; Ulcerative colitis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALANINE AMINOTRANSFERASE; ALBUMIN; LIVER ENZYME; VITAMIN D; 25-HYDROXYVITAMIN D; ALBUMINOID;

ADOLESCENT; AGE DISTRIBUTION; ALBUMIN BLOOD LEVEL; ARTICLE; AUTUMN; BODY MASS; CASE CONTROL STUDY; CAUCASIAN; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; ENTERITIS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEPATITIS; HUMAN; INFLAMMATORY BOWEL DISEASE; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; PROTEIN LOSING GASTROENTEROPATHY; RETROSPECTIVE STUDY; SKIN PIGMENTATION; SPRING; SUMMER; SUNLIGHT; VITAMIN D DEFICIENCY; WINTER; ANALOGS AND DERIVATIVES; BLOOD; ENZYMOLOGY; IMMUNOLOGY; INFLAMMATION; LIVER; SEASON; YOUNG ADULT;

ADIPOSITY; ADOLESCENT; ALANINE TRANSAMINASE; ALBUMINS; BLOOD SEDIMENTATION; BODY MASS INDEX; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; LIVER; MALE; OVERWEIGHT; PREVALENCE; RETROSPECTIVE STUDIES; SEASONS; SKIN PIGMENTATION; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84945910761     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2015.03.010     Document Type: Article

References (27)

1. Pappa H.M., Langereis E.J., Grand R.J., Gordon C.M. Prevalence and risk factors for hypovitaminosis D in young patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2011, 53:361-364.
2. Pappa H.M., Gordon C.M., Saslowsky T.M., Zholudev A., Horr B., Shih M.C., et al. Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 2006, 118:1950-1961.
3. Pappa H.M., Grand R.J., Gordon C.M. Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflamm Bowel Dis 2006, 12:1162-1174.
4. Nwosu B.U., Stavre Z.G., Maranda L., Cullen K., Lee M.M. Hepatic dysfunction is associated with vitamin D deficiency and poor glycemic control in diabetes mellitus. J Pediatr Endocrinol Metab 2012, 25:181-186.
5. Rojas-Feria M., Castro M., Suarez E., Ampuero J., Romero-Gomez M. Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver. World J Gastroenterol 2013, 19:7327-7340.
6. Vimaleswaran K.S., Berry D.J., Lu C., Tikkanen E., Pilz S., Hiraki L.T., et al. Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 2013, 10:E1001383.
7. Setty-Shah N., Maranda L., Candela N., Fong J., Dahod I., Rogol A.D., et al. Lactose intolerance: lack of evidence for short stature or vitamin D deficiency in prepubertal children. PLoS One 2013, 8:E78653.
8. Zwintscher N.P., Horton J.D., Steele S.R. Obesity has minimal impact on clinical outcomes in children with inflammatory bowel disease. J Pediatr Surg 2014, 49:265-268. discussion 268.
9. Long M.D., Crandall W.V., Leibowitz I.H., Duffy L., del Rosario F., Kim S.C., et al. Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease. Inflamm Bowel Dis 2011, 17:2162-2168.
10. Goodhand J.R., Kamperidis N., Joshi N.M., Wahed M., Koodun Y., Cantor E.J., et al. The phenotype and course of inflammatory bowel disease in UK patients of Bangladeshi descent. Aliment Pharmacol Ther 2012, 35:929-940.
11. Middleton J.P., Bhagavathula A.P., Gaye B., Alvarez J.A., Huang C.S., Sauer C.G., et al. Vitamin D status and bone mineral density in African American children with Crohn disease. J Pediatr Gastroenterol Nutr 2013, 57:587-593.
12. Bours P.H., Wielders J.P., Vermeijden J.R., van de Wiel A. Seasonal variation of serum 25-hydroxyvitamin D levels in adult patients with inflammatory bowel disease. Osteoporos Int 2011, 22:2857-2867.
13. Levin A.D., Wadhera V., Leach S.T., Woodhead H.J., Lemberg D.A., Mendoza-Cruz A.C., et al. Vitamin D deficiency in children with inflammatory bowel disease. Dig Dis Sci 2011, 56:830-836.
14. IBD Working Group of the European Society for Paediatric Gastroenterology Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis-the Porto criteria. J Pediatr Gastroenterol Nutr 2005, 41:1-7.
15. Svoren B.M., Volkening L.K., Wood J.R., Laffel L.M. Significant vitamin D deficiency in youth with type 1 diabetes mellitus. J Pediatr 2009, 154:132-134.
16. Kuczmarski R.J., Ogden C.L., Guo S.S., Grummer-Strawn L.M., Flegal K.M., Mei Z., et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11 2002, 11:1-190.
17. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011, 96:1911-1930.
18. Sacheck J., Goodman E., Chui K., Chomitz V., Must A., Economos C. Vitamin D deficiency, adiposity, and cardiometabolic risk in urban schoolchildren. J Pediatr 2011, 159:945-950.
19. Ross A.C., Manson J.E., Abrams S.A., Aloia J.F., Brannon P.M., Clinton S.K., et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011, 96:53-58.
20. Skaaby T., Husemoen L.L., Borglykke A., Jorgensen T., Thuesen B.H., Pisinger C., et al. Vitamin D status, liver enzymes, and incident liver disease and mortality: a general population study. Endocrine 2014, 47:213-220.
21. Autier P., Boniol M., Pizot C., Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2014, 2:76-89.
22. Cohen-Lahav M., Douvdevani A., Chaimovitz C., Shany S. The anti-inflammatory activity of 1,25-dihydroxyvitamin D3 in macrophages. J Steroid Biochem Mol Biol 2007, 103:558-562.
23. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
24. Zhu Y., Mahon B.D., Froicu M., Cantorna M.T. Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway-suppress experimental inflammatory bowel disease. Eur J Immunol 2005, 35:217-224.
25. Canning M.O., Grotenhuis K., de Wit H., Ruwhof C., Drexhage H.A. 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur J Endocrinol 2001, 145:351-357.
26. SchleithoffS.S., Zittermann A., Tenderich G., Berthold H.K., Stehle P., Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006, 83:754-759.
27. El-Matary W., Sikora S., Spady D. Bone mineral density, vitamin D, and disease activity in children newly diagnosed with inflammatory bowel disease. Dig Dis Sci 2011, 56:825-829.